Search

Author Index

A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

 

I
I Wieland - Reproductive Choices, Pregnancies and Deliveries in Carriers of Hemophilia – Results of the CarrierQOL-Study
I Lopez I - Therapeutic Plasma Exchange (TPE) for Thrombotic Thrombocytopenic Purpura (TTP) Using Plasma Prepared With Photochemical Treatment: Clinical Responses, vWF CP Levels and vWF-CP Inhibitor Levels
Iaboni S - Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
  - Validation of Laboratory Reference Standards for Clinical Use of INR-POC Devices: A Randomized Multicentre Exercise
Iacobelli M - Defibrotide and Oligotide, Two DNA-Based Drugs, Protect Human Microvascular Endothelial Cells against Chemotherapy-Induced Damage and Activation
Iacone R - Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study
Iacoviello L - Association Between -675 4G/5G Polymorphism of the PAI-1 Gene and Obesity in Men: Longitudinal Findings of the Olivetti Heart Study
Iacoviello L - Genetic and Environmental Regulation of Factor VII Levels: Results from the IMMIDIET Project
Iacoviello L - C-Reactive Protein and Its Determinants in European Populations at Different Risk of Cardiovascular Disease: Results from the IMMIDIET Project
  - Polyphenolic Components of Extra Virgin Olive Oil: Effect on Arterial Thrombosis and Bioavailability in Rats
Iacoviello L - Comparison of Global Risk of Fatal Cardiovascular Disease in Three European Populations Using SCORE Equations: Results from the IMMIDIET Project
Iacoviello L - The -675 4G/5G Plasminogen Activator Inhibitor-1 Promoter Polymorphism in House Dust Mite Sensitive Allergic Asthma Patients
  - Walking and Modulation of Cardiovascular Risk Factors in Three European Populations: Results from the IMMIDIET Project
Iannaccaro P - Factor VIII Inhibitor in a Patient with Mild Haemophilia A
  - Fibrinogen Storage Disease with Hypofibrinogenaemia
Iannaccone L - Higher Warfarin Requirement in Anticoagulated Antiphospholipid Syndrome Patients to Acquire the Target INR
Iatsenko EA - The Long-term Future of Patients Had Had Henoch-Schonlein Purpura in Childhood
  - Ulcerous Colitis in Children with Hemophilia A
Ichihara M - Evaluation of GPIIb/IIIa Antagonist YM128 Using Monkeys with Photochemically-Induced Middle Cerebral Artery Occlusions
Ichimura K - Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy
Ichinose A - Measuring Concentration of Soluble Fibrinogen and Fibronectin Complexes (FG-FN) in Patient' Plasma with Various Diseases Using Two-Step Sandwich ELISA Method
  - Studies on the Structure and Function of Factor XIII in vitro and in vivo
  - Cardiac Involvement in Pathologic Findings of Factor XIII Knockout Mice
Ide L - High-Level Expression of Porcine Factor VIII from Genetically-Modified Bone Marrow-Derived Cell Types
Ieko M - Determination of IgM Phosphatidylserine Dependent Antiprothrombin Antibodies Improves the Diagnostic Yield of Antiphospholipid Syndrome
  - Factor VII Arg277His Mutation Induced Discrepancy of Factor VII Activity Levels Using Tissue Factor from Different Sources
Ifrah N - Evolution of Antithrombin (AT) and Fibrinogen (Fg) Levels during Induction Chemotherapy with L-asparaginase (Asp) in Adult Patients with Acute Lymphoblastic Leukemia (ALL) or Lymphoblastic Lymphoma (LBL). Clinical Outcomes and Use of Coagulation Supportive Treatments: The CAPELAL Study
Iglesias Varela ML - A Lower Calcium Concentration Prolongs More Frequently Dilute Prothrombin Time (dPT) of Patients with Lupus Anticoagulant (LA) and Anti-B2GPI Antibodies (aB2GPI)
  - Comparison Among the New Immunoassays with Monoclonal Antibody Calibration and Home-Made Methods for Testing the Antiphospholipid Antibody (APA) Family
Ignjatovic V - Tissue Factor Pathway Inhibitor (TFPI) Contributes to the Early Anticoagulant Effect of Unfractionated Heparin (UFH) during Haemodialysis
  - Heparin Monitoring During Haemodialysis in Children
Ignjatovic V - Multi Modal Management of Purpura Fulminans due to Homozygous Protein C Deficiency
  - Developmental Haemostasis and Response to Heparin Therapy in Children
  - Tissue Factor Pathway Inhibitor (TFPI) during Heparin Therapy in the Paediatric Intensive Care Unit (PICU)
Ignjatovic V - Tissue Factor Pathway Inhibitor (TFPI) during Cardiopulmonary Bypass (CPB) in Children
Ignjatovic V - Chromogenic and Clot Based Protein C Assays Contribute to the Management Of Homozygous Protein C Deficient Patients
Ignjatovic V - Monitoring Haemostasis in Cardiopulmonary Bypass in Children – Measures of Heparin Activity
  - Platelet Changes during Cardiopulmonary Bypass in Children
Ihara H - A Role for Adipocyte-enriched Transcription Factor, PPAR-g, in Up-regulation of PAI-1 Gene Expression during Adipogenesis
Ihara H - Protein S Suppresses Invasive Potential of THP-1 Cells by Lowering Binding Capacity of Plasminogen on Cell Surface
Ihara A - Hemostatic Factors and Serum Lipids in Patients with Angina Pectoris Who Underwent Coronary Angiography
Iijima K - Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency
Ikebe M - Molecular Cloning of 20-kDa Myosin Light Chain Isoforms in Human Platelets
Ikeda Y - Hemostatic Effects of Polymerized Albumin Particles Carrying Fibrinogen-g Chain Dodecapeptide as Platelet Substitutes in vitro and in vivo
  - Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100®
Ikeda M - Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital
Ikeda Y - Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver
Ikeda S - Nattokinase and Vitamin K2 Production Using Sake Cake, in Particular Distilled Cake, as the Fermented Material
Ikeda Y - Platelet aIIbb3 Integrin Constrained in the Extended Conformer Represents an Highly Activated Form
  - Hemostatic Effects of Polymerized Albumin Particles Carrying Recombinant Glycoprotein Iba as Platelet Substitutes in vitro and in vivo
Ikejiri M - Targeted Disruption of Mouse Ortholog of the Human MYH9 Responsible for Macrothrombocytopenia with Different Organ Involvement: Hematological, Nephrological, and Otological Studies of Heterozygous KO Mice
Ikemoto Y - Novel Function of Histidine-rich Glycoprotein with Cell Differentiation-promoting Activity
Ilan N - Effect of Heparanase on TF Expression and TFPI Release
Ilancheran A - Systemic Prognostic Haemostatic Marker Levels for Disease Outcome within Five Years from Ovarian Cancer
  - Systemic Pre-Operative Haemostatic Marker Levels and Their Association with Disease Outcome from Uterine Cervix and Endometrial Cancers Within 2 years
Ilari I - Combined Oral Anticoagulant and Antiplatelet Therapy And Bleeding Risk
Iles DE - Study Of TFPI T-287C Polymorphism in Relation to Venous Thrombosis; Association/Functional Analyses and Characterization of TFPI Promoter
Ilia T - Evaluation of Stability of Sucrose – Formulated, Full-Length Rfviii for Use in Continuous Infusion Therapy
Iliceto S - Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
Illán F - Non-enzymatic Glycation of Antithrombin: Implications in Diabetes Mellitus
Ilveskero S - Different Monitoring Methods for in Vitro and in Vivo Lepirudin, a Direct Thrombin Inhibitor: Diluted Thrombin Time (dTT), Activated Partial Thromboplastin Time (aPTT) and Ecarin Clotting Time (ECT)
Ilzecki M - The Use of Recombinant Activated Factor VII to Control Postoperative Bleeding in Patients Undergoing Abdominal Aortic Aneurysm Reconstruction
  - Fibrinolytic Activity in the Patients with Buerger's Disease and PAOD
Imamura T - Detection of von Willebrand Factor and Tissue Factor in Platelets-Fibrin Rich Coronary Thrombi Causing Acute Myocardial Infarction
  - Inhibition of 5-Hydroxytriptamine2A (5-HT2A) Receptor Prevents Occlusive Thrombus Formation on Neointima of Rabbit Femoral Artery
Imamura Y - Analyses of the Interaction of Platelet Collagen Receptor Glycoprotein (GP) VI with Various Types of Collagen
Imberti D - Prevalence of Thrombophilic Abnormalities in Patients with Deep Vein Thrombosis or Pulmonary Embolism
  - A Prospective Registry on the Long-Term Clinical Outcome of Venous Thromboembolism (Multicenter Advanced Study for a ThromboEmbolism Registry – MASTER): Description of the study cohort
  - Risk Factors for CVC-Associated Thrombosis in Cancer Patients: Analysis of the ETHIC Study
  - Duration of Anticoagulant Treatment and Recurrence of Venous Thromboembolism in Patients with and without Thrombophilia
Imberti D - Clinical Experience with Optional Vena Cava Filters: Results of a Prospective Observational Multicenter Study
Inaba H - Factor V Mutations, Arg2174Leu, a 5-bp Deletion and Val1813Met, Are Associated with Factor V Deficiency and A Bleeding Tendency
  - Four Novel Missense Mutations in Factor IX Gene Were Identified as Causes of Hemophilia B
Inácio RAS - Retrospective and Prospective Analysis of the Incidence of Venous Thromboembolism in First-Degree Relatives of Factor V Leiden and Factor II G20210A Carriers
Inbal A - Evaluation of Pro-angiogenic and Pro-Coagulant Activity of Irradiated, Non Irradiated and Filtered Stored Blood Used in Transfusion Practice
Inbal A - Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice
Inbal A - Impaired Healing of Cutaneous Wounds in Factor XIII-Deficient Mice
  - Evaluation of Pro-Angiogenic Activity of Factor XIII (FXIII) in Murine Models of Heart Transplantation and FXIII-Deficient Mice
Ince H - Cardiovascular Interventions and Surgery in Patients with Haemophilia and Von Willebrand Disease
Inder R - Molecular Pathways for Lymphangiogenesis and Their Role in Human Disease
Ing C - Utility of aPTT in Monitoring Unfractionated Heparin in Children
Ingelfinger JR - Do Detached Endothelial Cells and Microparticles Contribute to the Procoagulant Activity Observed in Hemolytic Uremic Syndrome?
  - Real-Time Imaging of Tissue Factor-Positive Microparticles in Flowing Blood
Ingerslev J - In vitro Expression of Ten Missense Mutations in the VWF C-Terminal Domain Identified in Patients Diagnosed with Type 1 VWD: Results from the MCMDM-1VWD Study
  - Recombinant Factor VIIa – Mechanism of Action Based on Dynamic Whole Blood Coagulation Studies
  - Collagen Binding (VWF : CB) Is Less Sensitive Than Ristocetin Cofactor Activity (VWF : RCo) in Suggesting Von Willebrand Factor (VWF) Molecular Defects in Patients with Von Willebrand Disease Type 1: Results From the European Multicenter MCMDM-1VWD Study
  - Analysis of Bleeding Score in Type 1 VWD Families in the MCMDM-1 Study
  - Association of FVIII/Von Willebrand Factor Measurements and PFA-100® with Bleeding Score in Type 1 Von Willebrand Disease (VWD) Families. The MCMDM-1 Study
  - Multimer Pattern in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
  - A Reduced VWF to FVIII Binding Capacity is not Uncommon in Patients With Type 1 Von Willebrand Disease: Results From the MCMDM-1VWD Study
  - Visualization of the Continuous APTT Coagulation Signature – Methods and Correlations to Continuous Thrombin Generation
  - Two Novel Type 1 Von Willebrand Disease Causing Mutations (G160W and N166I) in the Von Willebrand Factor Propeptide, Identified in the European Study MCMDM-1VWD, Are Responsible for Multimerization And Secretion Defects
  - Cysteine Mutations in the von Willebrand Factor D3 Domain Correlate with Multimerization Defects in Patients Previously Diagnosed with von Willebrand Disease Type 1 in Patients Entered in the European Multicentre Study MCMDM-1VWD
  - Linkage Analysis of von Willebrand Disease Type 1 Phenotype, von Willebrand Factor Levels and Bleeding Symptoms with Von Willebrand Factor Gene Locus in the European Multicenter MCMDM-1VWD Study
  - Mutation Profile in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD (MCMDM-1VWD)
  - Visualization of Dynamic Fibrin Formation from APTT Recordings Reflects More Heterogeneity in Patients with Severe Haemophilia A Than Conventional APTT Values
  - Abnormal Multimeric Pattern Is Not Associated with Increased Bleeding Symptoms in Index Cases of Families with Type 1 VWD. Results from the EU MCMDM-1 VWD Study
  - Responsiveness to Desmopressin: Influence of Genotype in Patients Diagnosed with Type 1 von Willebrand Disease in the European Study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 VWD
  - The Whole Blood Coagulation Profile in Hyperhomocysteinemic Patients with Prior Thrombosis is Changed by Folic Acid Treatment as Evaluated by roTEG Thrombelastography
  - Haemostatic Potential of a Novel Analogue of rFVIIa Versus rFVIIa on Dynamic Whole Blood Clot Formation in Blood from Patients with Severe Haemophilia A
  - The Incidence and Penetrance of Common VWF Gene Mutations in a Cohort of Type 1 VWD Patients: Results from the EU Funded MCMDM-1VWD Project
  - Assay of the von Willebrand Factor Propeptide (VWFpp) to Identify Type 1 von Willebrand Disease (VWD) Patients with a Decreased von Willebrand Factor (VWF) Survival Phenotype
  - The Factor VIII/von Willebrand Factor Antigen (FVIII/VWF : Ag) Ratio in Determining VWF Defects in Patients with von Willebrand Disease Type 1: Results from the European Multicenter MCMDM-1VWD Study
Ingersoll SB - Genetic Evidence that CD154 (CD40 Ligand) Plays a Pathophysiologic Role in the Systemic Coagulopathy Associated with Murine Models of Experimental Metastasis and Endotoxemia
Ingersoll S - CD40 and CD40 Ligand (CD40L) in Primary Hemostasis and Antibody-Mediated Platelet Activation
  - Experimental Metastasis and Tumor Cell-Induced Coagulopathy in Mice with Hemophilia A and the Effect of FVIII Replacement Therapy
Inguenaud C - Screening of Factor V Leiden (FVL) and Risk-Assessment of Venous Thrombosis in Non-FVL-Carriers: Comparison of Different Methods for Activated Protein C Resistance (APCR) Measurement
Iniesta JA - Deleterious Effect of the Common FXIII Val34Leu Polymorphism in Patients with Ischemic Stroke Treated with Fibrinolytic Therapy
  - Protective Role of the Platelet GP IIIa Polymorphism HPA-1 (PlA) in Subarachnoid Hemorrhage
Innocenti D - Thrombophilia in Patients with Spinal Cord Injury
  - C677T and A1298C MTHFR, A2756G MTR and 844ins68 CBS Gene Polymorphisms in Atrial Fibrillation
Inoue O - Laminin Stimulates Spreading of Platelets Through a6b1-dependent Activation of GPVI
Inoue O - Identification of CLEC-2 as a Novel Signalling Receptor for Rhodocytin in Platelets
  - Signaling Mediated by Glycoprotein Ib-IX-V/VWF Interaction Mainly Takes Place in GEMs In Human Platelets
Ioannidis G - Linear and Cyclic RGD Peptides Containing Salicylic Acid Derivatives and Their Antiplatelet Activity In Vitro
  - The Possible Protective Role of FXIII Leu34 Allele in Thromboembolic Episodes. Its Coexistence with FVL and PAI-1 (4G/5G) Mutations in Thrombophiliacs
  - Use Of F1+2 and TAT as Markers of Prothrombinase Activity in Hemophiliacs
  - HIT-II: Therapeutical Use of Fondaparinux (Our Experience)
  - Thrombophilic Mutations: A Comparison between the Microarray Technique and the Solid Phase Oligonucleotide Ligation Assay (SPOLA)
  - Drug induced inhibition of platelet function and immune hemolytic anemia (CASE REPORT)
  - An Inquiry into Death Causes Based on Autopsy Findings
Ionita H - Thrombotic Risk in a Romanian Family with Protein S: Deficient Members
Ionova V - Platelet Function in Patients with Cerebrovascular Pathology in Changes of Geomagnetic Field of Earth
  - Hemorheology, Hemostasis in Patients with Arterial Hypertension
  - Hemorheology, Hemostasis and Antiaggregate Activity of Endothelium in Patients with Hypertensive Small Deep Infarcts
  - Haemorheology and Haemostasis in Ischemic Cerebrovascular Diseases
Ionova V - The Evaluation of Disfunction of Endothelium in Patients with Atherosclerosis of Carotid System and Reversible Neurological Deficit
Iorio A - Safety and Efficacy of Ximelagatran: Meta-Analysis of the Controlled Randomized Trials for the Prophylaxis or Treatment of Venous Thromboembolism
  - Validation of Laboratory Reference Standards for Clinical Use of INR-POC Devices: A Randomized Multicentre Exercise
Iorio A - The D-dimer (DD) Test to Establish the Duration of Anticoagulation after a First Unprovoked Episode of Venous Thromboembolism (VTE); the Prospective Randomized ‘Prolong’ Study on behalf of the Italian Federation of Anticoagulation Clinics (FCSA)
Iorio A - Coagulation Screening for Otorhinolaryngoiatric Surgery: A Pharmacoeconomic Appraisal in the Setting of the Italian National Health System
Iorio A - Host-Drug Interaction: The Influence of Small Intestinal Bacterial Overgrowth on Oral Anticoagulant Dose Requirement
Iorio AM - Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
Iorio A - Absence of Interaction Between Influenza Vaccination and Oral Anticoagulant Therapy: A Randomized Blinded Clinical Trial
  - Determinants of Mortality in Cerebral Hemorrhage Patients on Antithrombotic Treatment: Prospective Evaluation in the Italian Emergency Departments of a Multicentric Cohort of 1071 Patients
Iotti M - Venous Thromboembolism and the Risk of Subsequent Symptomatic Atherosclerosis
  - Resistance to Activated Proteine C (aPCR) in Subjects ‘Negative’ for Factor V Leiden (FVL) and ‘Positive’ for Antiphospholipid Antibodies (APL)
  - Different Intracytoplasmatic Pattern of BCL-2 Family Proteins in Lymphocytes from Subjects Positive for Antiphospholipid Antibodies (APL)
Iqbal O - Nitric Oxide Levels Are Elevated in Patients with Malignancy Associated Hypercoagulable State
  - Elevated Nitric Oxide Levels with Brachytherapy Compared to Bare Metal or Sirolimus Eluting Stents. Implications in Coronary Restenosis
  - Nitric Oxide Generation During Parenteral Administration Differentiates Argatroban from Lepirudin and Bivalirudin
  - Comparative Anticoagulant Effects of a Synthetic, Dual Antithrombotic/Antiplatelet Agent, CanAm 208, with Argatroban and Angiomax
  - Upregulation of Inflammatory Mediators in ESRD Patients: Pathophysiologic Implications
  - Protein Chip Array Profiles in End Stage Renal Disease (ESRD) Patients
  - Enoxaparin (E) and Warfarin (W) Differentially Regulate Tissue Factor (TF), Tissue Factor Pathway Inhibitor (TFPI) and Thrombin Activatable Fibrinolytic Inhibitor (TAFI) in Cancer Patients with Thrombosis
Iqbal O - Synthetic Anti-Xa Drugs but not Fondaparinux Can Be Used for Surgical and Interventional Anticoagulation
Iqbal O - Comparative Study on the Anticoagulant Effects of Low Molecular Weight Heparins As Measured by Whole Blood ACT, Anti-Xa and a Newly Developed Prothrombinase Induced Clotting Time (PiCT) Assay
  - Hyperhomocysteinemia in Cancer Patients with Thrombosis Is Not Associated with Methylene Tetrahydrofolate Reductase (MTHFR) Gene Mutations and Can Be Down Regulated by Low Molecular Weight Heparin Treatment
  - Cross Validation of the 2nd International Standard of Low Molecular Weight Heparin (IS 2003–01/608) in the Anti-Xa, Anti-Iia Heptest and PiCT Tests
  - Differential Modulation of Thrombin Activatable Fibrinolytic Inhibitor by Unfractionated Heparin
Iqbal A - Circulating Inhibitor in an Elderly Female That Impairs the Action of Human But Not Rabbit Brain Thromboplastin
Iqbal O - Differential Digestion of LMWHs By Heparinase-I and Heparinase-II: Drug Developmental Implications
  - Antithrombotic Mechanism of Action of BAY 59-7939 – a Novel, Oral, Direct Factor Xa Inhibitor
  - Betaine, a Novel Anticoagulant with Combined Nitric Oxide and Tissue Factor Pathway Release Potential. Implications in the Management of Peripheral Vascular Diseases
  - Antithrombotic Effects of Bacterial K5-Derived Sulfaminoheparosans in a Jugular Vein Crush Model of Thrombosis in Rats
Irani M - Use of the Platelet Function Analyzer (PFA-100) in Screening for Platelet Function Defects
Ireland H - Measurements of Soluble Thrombomodulin Activity and Antigen: Factors Contributing to Variance and Potential for Identification of Protein Variants
Ireland H - Cardiovascular Risk Factors Contributing to Endogenous Thrombin Potential (ETP) in Type 2 Diabetes
Iriondo A - Vein Trombosis in Pediatric Patients
  - Hemostatic Abnormalities in Oncolgic Patients
Isaac G - Importance of Temporal Flow Gradients and Integrin aIIbb3 Mechanotransduction for Shear-Activation of Platelets
Isermann B - Hyperglycemia Induces Loss of the Protective Endothelial Thrombomodulin Protein C System
Isgro F - Monitoring of Heparinization during Extracorporeal Circulation (ECC) with the New Anti-Factor Xa (FXa) Point-of-Care (POC) Clotting Assay Heptest-POC-Hi™
Ishida N - Circadian Clock Genes are Involved in the Regulation of fibrinolytic Activities in Mice
Ishida H - Antithrombotic Mechanisms Achieved by Selective Extraction of Cholesterol from Platelet Membrane by Methyl-b-Cyclodextrin
Ishida T - Intervention of Plasminogen Activator Inhibitor-1 in Nasal Allergy
Ishida N - Circadian Oscillation of Thrombomodulin Gene Expression in Peripheral Tissues
Ishihara H - Hepatocytes are the Major Site of ADAMTS-13 Expression in Human Liver
  - Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100®
Ishii H - Verotoxin-1 Activation of the c-Yes in Human Monocytes/THP-1 Monocytic Cells Induces Tissue Factor Expression Through Activations of IKKbeta/NF-kappaB/Rel and ERK/Egr-1 Pathways
Ishii H - Thrombomodulin Inhibits Tumor Cell Invasion Through Three Different Domains of the Molecule
  - Injury-Inducible Yin Yang-1 Inhibits Vascular Smooth Muscle Cell Growth and Intimal Thickening by Repressing p21WAF1/Cip1 Transcription and Perturbing Cyclin D1-Cdk4-p21WAF1/Cip1 Assembly
Ishikawa M - Stellate Cells Produce ADAMTS13 in Human Liver
Ishiwata A - Phenotype Correction of Hemophilia a Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
  - Phenotype Correction of Hemophilia A Mice with Adeno-associated Virus (AAV) Vectors Carrying the B domain Deleted Canine Factor VIII Gene
Isobe K - Recombinant Factor VIIa Reverses Te Prolonged Bleeding Time Induced B A High Dose of DU-176b, a Novel Direct Factor Xa inhibitor, In Rats
  - Antithrombotic Properties of DU-176b, a Novel Orally Active Factor Xa Inhibitor: Inhibition of both Arterial and Venous Thrombosis, and Combination Effects with Other Antithrombotic Agents
Isobe T - Comparative Antiplatelet Effects of the Active Metabolites of CS-747 (Prasugrel, LY640315) and Clopidogrel
  - Effective Inhibition of Platelet Aggregation and Release Reaction with Lack of Effect on Shape Change by CS-747 (Prasugrel, LY640315) and Its Active Metabolite
  - Critical Role of the Age-Related Homeostasis Mechanism in Amelioration of Hemophilia B Leyden: Role of Growth Hormone and Signal Transduction Network
Isobe K - Pharmacological Characterization, Antithrombotic and Bleeding Effects of DU-176b, a Novel, Potent and Orally Active Direct Inhibitor of Factor Xa: A Wider Safety Margin of Antithrombotic and Bleeding Effects Compared to Heparin, LMWH and Warfarin
Isobe H - Characterization and Thrombogenicity of Microparticles Derived from Endothelial Cells, Smooth Muscle Cells, and Monocytes as Measured By a Novel Thrombin Generation Assay (TECHNOTHROMBIN® TGA)
Isordia-Salas I - A Monoclonal Antibody to High Molecular Weight Kininogen Reduces Inflammation in the HLA-B27 Transgenic Rat Model of Inflammatory Bowel Disease and Arthritis
  - High Molecular Weight Kininogen (HK) Fragments Stimulate the Secretion of Interleukin 1b (IL-1b) through CD11b/CD18 (Mac-1) in Human Blood Mononuclear Cells
  - The Antithrombotic Activity of Kininogen is Mediated by Inhibitory Effects of Domain 3 on Thrombin-Induced Platelet Activation, In Vivo
Israels S - Results from the Canadian Hemophilia Dose Escalation Prophylaxis Trial: An Update
Israels SJ - The Tetraspanin CD63 and Phosphatidylinositol 4-Kinase Type II Co-Localize in Resting Platelets and Are Associated with Lipid Rafts Following Platelet Activation
Isturiz M - Regulation of Megakaryocyte Generation by Monocytes/Macrophages
  - Role of Human Polymorphonuclear Neutrophils in Endothelial Cell Damage Induced by Shiga Toxin-1 and Inflammatory Agents
Itakura H - Is the Novel Genetic Mutation, Prothrombin C20209T, an Independent Risk Factor for Stroke among African-Americans with Sickle Cell Anemia?
Italiano J - Platelet Shape and Formation
Itani Y - Pulmonary Thromboembolism in Cancer Patients Autopsied in a Japanese General Hospital
Ito T - Thrombomodulin Binds Lethal Cytokine HMGB1 and Neutralizes Its Pro-inflammatory Activity: Novel Cytoprotective Action of Thrombomodulin
Ito K - Hematopoietic Stem Cells and Their Niche
Ivanciu L - Tissue Factor Pathway Inhibitor-2 Inhibits in vitro Endothelial Cell Migration and Angiogenesis
Ivanková J - Beta-Thromboglobulin, Platelet Factor 4 and Soluble P-Selectin in Hemodialysis Patients with EPO Therapy
  - Plasma TFPI Levels in Patients Undergoing Regular Hemodialysis and Treated with Erythropoietin
Ivaskevicius V - Genetic variants in COX 1-, GP Ia/IIb- and FXIIIa-subunits: Effects on Response to Aspirin in Patients with Peripheral Arterial Occlusive Disease
  - Cranial Epidural Bleeding in a Child with Congenital Afibrinogenaemia, Management and Long-Term-Prophylaxis with a Fibrinogen Concentrate
  - Mutations in the VKORC1 Gene Cause Warfarin Resistance, Warfarin Sensitivity and Combined Deficiency of Vitamin K Dependent Coagulation Factors
Iversen N - Effects of Heparins on the Anticoagulant Function of Endothelial Tissue Factor Pathway Inhibitor (TFPI)
  - 17b-Estradiol Lowers Production of Tissue Factor Pathway Inhibitor (TFPI) in HUVEC Cells
Ivey L - Measurement of Von Willebrand Activity Using an Automated Latex Agglutination Technique Adapted for Use on the STA-Compact Coagulation Analayser
Iwamoto T - Stellate Cells Produce ADAMTS13 in Human Liver
Iwamoto M - Effects of Recombinant Antithrombin Expressed in Chinese Hamster Ovary Cells on Endotoxin- or Thromboplastin-Induced DIC in Rats and Concanavalin A-Induced Liver Injury in Mice
Iwaniec T - Kinetics of Thrombin Formation at the Site of Microvascular Injury: Effects of Coagulation Factors and Oral Anticoagulation
  - Thrombin Generation after Therapy with Lipid-Lowering Drugs in High Cardiovascular Risk Subjects Supplemented with Folic Acid
  - Rapid Antithrombotic and Anti-platelet Effects of Simvastatin and Micronized Fenofibrate in Patients with Hypercholesterolemia
  - The Angiotensin-Converting Enzyme Gene Insertion/Deletion Polymorphism and Effects of Quinapril and Atorvastatin on Haemostatic Parameters in Patients With Coronary Artery Disease
  - Factor VIII Levels and Blood Coagulation in Patients on Long-Term Oral Anticoagulation (OA)
Iwashita M - Individual Variation of Platelet Functions after in vitro Incubation with Aspirin: Assessment of Aspirin Resistance in Healthy Subjects Using PFA-100®
Iyengar SS - Relationship Among Antibody Against Cytomegalovirus (CMV), Plasma Interleukin-6 (IL-6) and Coronary Artery Disease (CAD) – Preliminary Findings of the Indian Atherosclerosis Research Study (IARS)
  - Adult Non-Twin Sib Concordance Rates for Non-Insulin Dependent Diabetes Mellitus (NIDDM) and Hypertension in Asian Indian Population
  - Heritability of Triglyceride and Relationship with Sac-1 Polymorphism in 3'-Untranslated Region (UTR) of Apolipoprotein CIII Gene: Linkage of Apolipoprotein CIII Locus (Chromosome 11 q23) and Association of Variant Allele with Coronary Artery Disease (CAD)
  - Heritability of Quantitative Phenotypes: Lipids, Coagulation, Pro-Inflammatory, Cell Adhesion and Anthropometric Markers in the Presence or Absence of Coronary Artery Disease (CAD) in Parents
Izraeli S - A Novel Mutation In Platelet Glycoprotein Iba Causing Bernard–Soulier Syndrome In A Bucharian Jewish Family
Izui S - Mice Lacking Gas6 are Protected from Graft-Versus-Host Disease in the Liver Due to a Reduced Activation of the Endothelium
Izzo M - Common Factor XIII Gene Polymorphisms in Venous Leg Ulcers